These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18544543)

  • 1. Thrombogenicity in patients with percutaneous coronary artery intervention and dual antiplatelet treatment.
    Kamphuisen PW
    Eur Heart J; 2008 Jul; 29(14):1699-700. PubMed ID: 18544543
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y; Ohmori T; Hoshide S; Madoiwa S; Yamamoto K; Katsuki T; Mitsuhashi T; Mimuro J; Shimada K; Kario K; Sakata Y
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on dual antiplatelet therapy for percutaneous coronary intervention.
    Prasad A; Holmes DR
    Heart; 2009 Jun; 95(11):861-5. PubMed ID: 19372090
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel?
    Wiviott SD
    Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention.
    Palmerini T; Marzocchi A; Tamburino C; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; Di Pede F; Ramondo A; Inglese L; De Carlo M; Bolognese L; Benassi A; Palmieri C; Filippone V; Sangiorgi D; Barlocco F; Lauria G; De Servi S
    J Am Coll Cardiol; 2009 Apr; 53(14):1176-81. PubMed ID: 19341857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the glass 97% full, or 3% empty? Reinfarction and stent thrombosis after STEMI.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):635-6. PubMed ID: 19309703
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
    Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
    Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention before noncardiac surgery: more threat than benefit?
    Mendoza CE; Shah N; Virani S
    J Am Coll Cardiol; 2004 Feb; 43(4):713-4; author reply 714-5. PubMed ID: 14975490
    [No Abstract]   [Full Text] [Related]  

  • 10. Stent thrombosis after percutaneous coronary intervention for bifurcation lesions.
    Tan HC
    J Interv Cardiol; 2009 Apr; 22(2):114-6. PubMed ID: 19379468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
    Tan VP; Yan BP; Kiernan TJ; Ajani AE
    Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent very late drug-eluting stent thrombosis.
    Pesarini G; Arieti M; Spadaro R; Vassanelli C; Ribichini F
    Cardiovasc Revasc Med; 2009; 10(2):130-5. PubMed ID: 19327678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A; Curzen N
    Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
    [No Abstract]   [Full Text] [Related]  

  • 16. Exclusive antiplatelet therapy for percutaneous coronary intervention.
    Denardo SJ
    J Am Coll Cardiol; 2009 May; 53(20):1921-2; author reply 922-3. PubMed ID: 19442895
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
    Bhatt DL
    Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
    Milani RV
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.